Delivery Order FA486119DA002-FA486121F0033

The Department of the Air Force Air Combat Command awarded Biofire Diagnostics, LLC a $92,574.08 firm fixed price delivery order for BIOFIRE REAGENTS. The contract has an anticipated completion date of August 17, 2019 and was awarded on July 24, 2019. The place of performance is Nellis Air Force Base in Nevada. No set-aside designation was used for this procurement. Biofire Diagnostics, LLC will provide reagents in support of Air Combat Command operations at Nellis Air Force Base under the terms...

Biofire Diagnostics, LLC was awarded a delivery order against the Department of the Air Force Air Combat Command's indefinite-delivery/indefinite-quantity contract vehicle to provide $203,536.78 worth of products and services in support of the agency's mission needs from July 2022 through July 2023. The firm fixed price delivery order was awarded on July 13, 2022 to the prime contractor Biofire Diagnostics, LLC for performance at Nellis Air Force Base in Nevada. No set-aside provisions were...

Biofire Diagnostics, LLC was awarded a $136,129 firm fixed price delivery order against an unidentified contract vehicle by the Department of the Air Force Air Combat Command. The delivery order, designated BIOFIRE FY20 DELIVERY ORDER, has a period of performance through July 18, 2021 and was awarded on July 31, 2020 without a set-aside designation. The place of performance is Nellis Air Force Base in Nevada. While details of the products or services requested were not provided, this appears...

Biofire Diagnostics, LLC was awarded a $211,851.78 firm fixed price delivery order against an unidentified contract vehicle by the Department of the Air Force Air Combat Command. The delivery order, designated BIOFIRE FY21 DELIVERY ORDER, has a period of performance through July 18, 2022 and was awarded on July 19, 2021 without a set-aside designation. The place of performance is Nellis Air Force Base in Nevada. No major subcontractors or additional context regarding the Air Combat Command's...

The Department of the Air Force awarded a definitive contract valued at $33.1 million to Biofire Defense LLC of Salt Lake City, Utah. The firm fixed price contract is to provide "COVID 19" BIOFIRE RESPIRATORY 2.1 (RP2.1) PANEL WITH SARS_COV-2 diagnostic testing kits compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. The solicitation sought proposals to supply these BioFire Respiratory 2.1 panels to detect SARS-CoV-2 and 21 additional respiratory pathogens...

The Department of the Air Force Air Combat Command awarded a $295,000 firm fixed price purchase order to Biofire Defense LLC. The contract calls for Biofire Defense to deliver one Biofire Torch System Base, three Biofire Torch Duplex units, and eight Biofire Torch Modules to the 366th Financial Acquisition Squadron at Mountain Home Air Force Base in Idaho. The solicitation sought quotes for these goods to support diagnostic testing at a military treatment facility on base. As the original...

The U.S. Air Force's Air Combat Command awarded a $112,000 firm fixed-price purchase order to Biofire Diagnostics LLC on April 2, 2020, for COVID-19 tests to support operations at Langley Air Force Base in Virginia. The contract, which represents an urgent procurement response to the coronavirus pandemic, was completed by April 17, 2020. This award was issued without a set-aside designation, reflecting Biofire Diagnostics' competitive standing in the federal marketplace. The contract likely...

This is a firm fixed-price purchase order awarded by the Air Combat Command (ACC) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company based in Salt Lake City, Utah. The $434,982.96 contract is for the provision of Biofire's FilmArray diagnostic systems, COVID-19 testing reagents, infectious disease testing panels, equipment maintenance services, and cost-per-test diagnostic solutions. The contract does not have a set-aside designation, indicating open competition....

This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, is for the supply of BIOFIRE RESPIRATORY PANELS RP2.1 with a potential value of $233,601.96. The contract was awarded by the Department of the Air Force Air Combat Command, under a Firm Fixed Price purchase order, with the place of performance at Nellis AFB, NV. This award is not designated as a set-aside. Biofire Diagnostics LLC is the leader in syndromic infectious disease testing and has...

This contract was awarded by the Department of the Air Force Air Combat Command to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE RP2.1 PANELS. The contract is a firm fixed-price purchase order with a potential value of $213,463.86 and a completion date of August 6, 2021. No set-aside was used for this award. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards, including from the...